RICHARD CHRISTOPHER Insider Trading $DUSA DUSA PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RICHARD CHRISTOPHER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RICHARD CHRISTOPHER. RICHARD CHRISTOPHER is CFO, EVP in ICAD INC ($ICAD) and Executive VP and CFO in ICAD INC ($ICAD) and VP Fin'l Plng & Bus. Analysis in DUSA PHARMACEUTICALS INC ($DUSA) and VP Finance & CFO in DUSA PHARMACEUTICALS INC ($DUSA) and CFO and Treasurer in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV).
RICHARD CHRISTOPHER in DUSA PHARMACEUTICALS INC
Trading Symbol: DUSAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of RICHARD CHRISTOPHER: VP Finance & CFO, VP Fin'l Plng & Bus. Analysis
Holdings: 0 shares
Latest Transaction: Dec 20 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RICHARD CHRISTOPHER in DUSA PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, DUSA, ICAD, NVIV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 1.65 | 85,000 | 140,250 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 1.22 | 37,550 | 45,811 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 2.20 | 19,500 | 42,900 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 3.37 | 20,000 | 67,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 6.75 | 20,000 | 135,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 10.00 | 25,000 | 250,000 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | D | 9.92 | 20,000 | 198,400 | 0 | |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | U | 8.00 | 209,150 | 1,673,200 | 0 | 209.2 K to 0 (-100.00 %) |
Dec 20 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | U | 8.00 | 66,862 | 534,896 | 0 | 66.9 K to 0 (-100.00 %) |
Nov 13 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | M | 1.60 | 7,500 | 12,000 | 0 | |
Nov 13 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Buy | M | 1.60 | 7,500 | 12,000 | 276,012 | 268.5 K to 276 K (+2.79 %) |
May 11 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 6.13 | 1,030 | 6,314 | 268,512 | 269.5 K to 268.5 K (-0.38 %) |
Mar 15 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 5.86 | 2,980 | 17,463 | 269,542 | 272.5 K to 269.5 K (-1.09 %) |
Mar 09 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Grant | A | 0.00 | 130,000 | 0 | 272,522 | 142.5 K to 272.5 K (+91.21 %) |
Mar 09 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 6.05 | 5,151 | 31,164 | 142,522 | 147.7 K to 142.5 K (-3.49 %) |
Mar 07 2012 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 4.65 | 3,329 | 15,480 | 147,673 | 151 K to 147.7 K (-2.20 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | M | 3.87 | 5,000 | 19,350 | 0 | |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | M | 1.22 | 37,550 | 45,811 | 0 | |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.90 | 5,000 | 29,507 | 151,002 | 156 K to 151 K (-3.21 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.89 | 50 | 295 | 156,002 | 156.1 K to 156 K (-0.03 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.91 | 5,000 | 29,534 | 156,052 | 161.1 K to 156.1 K (-3.10 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.91 | 2,500 | 14,775 | 161,052 | 163.6 K to 161.1 K (-1.53 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.94 | 15,000 | 89,028 | 163,552 | 178.6 K to 163.6 K (-8.40 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.95 | 300 | 1,785 | 178,552 | 178.9 K to 178.6 K (-0.17 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.96 | 1,800 | 10,728 | 178,852 | 180.7 K to 178.9 K (-1.00 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.97 | 4,400 | 26,268 | 180,652 | 185.1 K to 180.7 K (-2.38 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.98 | 500 | 2,988 | 185,052 | 185.6 K to 185.1 K (-0.27 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.98 | 6,900 | 41,262 | 185,552 | 192.5 K to 185.6 K (-3.59 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.98 | 300 | 1,795 | 192,452 | 192.8 K to 192.5 K (-0.16 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.99 | 100 | 599 | 192,752 | 192.9 K to 192.8 K (-0.05 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Sell | S | 5.99 | 700 | 4,193 | 192,852 | 193.6 K to 192.9 K (-0.36 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Buy | M | 3.87 | 5,000 | 19,350 | 193,552 | 188.6 K to 193.6 K (+2.65 %) |
May 13 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Buy | M | 1.22 | 37,550 | 45,811 | 188,552 | 151 K to 188.6 K (+24.87 %) |
May 11 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 5.80 | 1,032 | 5,986 | 151,002 | 152 K to 151 K (-0.68 %) |
Mar 14 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 4.15 | 2,985 | 12,388 | 152,034 | 155 K to 152 K (-1.93 %) |
Mar 08 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Grant | A | 0.00 | 65,000 | 0 | 155,019 | 90 K to 155 K (+72.21 %) |
Mar 08 2011 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 3.95 | 3,334 | 13,169 | 90,019 | 93.4 K to 90 K (-3.57 %) |
May 10 2010 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 2.01 | 1,032 | 2,074 | 93,353 | 94.4 K to 93.4 K (-1.09 %) |
Mar 16 2010 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Payment of Exercise | F | 1.78 | 3,215 | 5,723 | 94,385 | 97.6 K to 94.4 K (-3.29 %) |
Mar 08 2010 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | A | 0.00 | 85,000 | 0 | 85,000 | |
Mar 08 2010 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Grant | A | 0.00 | 42,000 | 0 | 97,600 | 55.6 K to 97.6 K (+75.54 %) |
Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | A | 1.22 | 75,100 | 91,622 | 75,100 | |
Mar 17 2009 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Grant | A | 0.00 | 37,600 | 0 | 55,600 | 18 K to 55.6 K (+208.89 %) |
Aug 19 2008 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Grant | A | 2.00 | 5,000 | 10,000 | 83,250 | 78.3 K to 83.3 K (+6.39 %) |
May 12 2008 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | A | 2.20 | 19,500 | 42,900 | 19,500 | |
May 12 2008 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Grant | A | 0.00 | 13,000 | 0 | 13,000 | 0 to 13 K |
Mar 21 2007 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | A | 3.37 | 20,000 | 67,400 | 109,500 | |
Mar 29 2006 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | A | 6.75 | 20,000 | 135,000 | 20,000 | |
Mar 21 2005 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Finance & CFO | Option Exercise | A | 10.00 | 25,000 | 250,000 | 25,000 | |
Mar 22 2004 | DUSA | DUSA PHARMACEUTICA ... | CHRISTOPHER RICHARD | VP Fin'l Plng & Bus ... | Option Exercise | A | 9.92 | 20,000 | 198,400 | 20,000 |
Page: 1